323 related articles for article (PubMed ID: 15488313)
21. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.
Zheng B; Wiklund F; Gharizadeh B; Sadat M; Gambelunghe G; Hallmans G; Dillner J; Wallin KL; Ghaderi M
Anticancer Res; 2006; 26(5B):3669-74. PubMed ID: 17094383
[TBL] [Abstract][Full Text] [Related]
22. CCR2-64I is a risk factor for development of bladder cancer.
Narter KF; Agachan B; Sozen S; Cincin ZB; Isbir T
Genet Mol Res; 2010 Apr; 9(2):685-92. PubMed ID: 20449800
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.
Breunis WB; Biezeveld MH; Geissler J; Kuipers IM; Lam J; Ottenkamp J; Hutchinson A; Welch R; Chanock SJ; Kuijpers TW
Clin Exp Immunol; 2007 Oct; 150(1):83-90. PubMed ID: 17672867
[TBL] [Abstract][Full Text] [Related]
24. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population.
Cheong JY; Cho SW; Choi JY; Lee JA; Kim MH; Lee JE; Hahm KB; Kim JH
J Korean Med Sci; 2007 Jun; 22(3):529-35. PubMed ID: 17596666
[TBL] [Abstract][Full Text] [Related]
25. Allograft renal rejection and chemokine polymorphism.
Gorgi Y; Sfar I; Jendoubi-Ayed S; Makhlouf M; Rhomdhane TB; Bardi R; Aouadi H; Abdallah TB; Abderrahim E; Ayed K
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):18-23. PubMed ID: 21196609
[TBL] [Abstract][Full Text] [Related]
26. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
Li H; Liu TJ; Hong ZH
Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
[TBL] [Abstract][Full Text] [Related]
27. Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis.
Soto-Sánchez J; Santos-Juanes J; Coto-Segura P; Coto E; Díaz M; Rodríguez I; Alvarez V
Cytokine; 2010 May; 50(2):114-6. PubMed ID: 20153665
[TBL] [Abstract][Full Text] [Related]
28. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.
Hellier S; Frodsham AJ; Hennig BJ; Klenerman P; Knapp S; Ramaley P; Satsangi J; Wright M; Zhang L; Thomas HC; Thursz M; Hill AV
Hepatology; 2003 Dec; 38(6):1468-76. PubMed ID: 14647058
[TBL] [Abstract][Full Text] [Related]
29. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
30. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population.
Huerta C; Castro MG; Coto E; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; Martínez C; Lahoz CH; Alvarez V
J Neurol Sci; 2005 Sep; 236(1-2):49-54. PubMed ID: 15975594
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-24, RANTES and CCR5 gene polymorphisms are not associated with chronic adult periodontitis.
Savarrio L; Donati M; Carr C; Kinane DF; Berglundh T
J Periodontal Res; 2007 Apr; 42(2):152-8. PubMed ID: 17305874
[TBL] [Abstract][Full Text] [Related]
33. MCP-1 and CCR2 gene polymorphisms in Czech patients with allergic disorders.
Holla LI; Mrazek F; Petrek M
Int J Immunogenet; 2009 Feb; 36(1):69-72. PubMed ID: 19055601
[TBL] [Abstract][Full Text] [Related]
34. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
35. Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica.
Hisada M; Lal RB; Masciotra S; Rudolph DL; Martin MP; Carrington M; Wilks RJ; Manns A
J Infect Dis; 2002 May; 185(9):1351-4. PubMed ID: 12001056
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the involvement of CCR5-Delta32 and CCR2-V64I variants in the development of endometriosis.
Antiñolo G; Fernández RM; Noval JA; Moliní JL; Borrego S
Mol Hum Reprod; 2004 Mar; 10(3):155-7. PubMed ID: 14981141
[TBL] [Abstract][Full Text] [Related]
37. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
[TBL] [Abstract][Full Text] [Related]
38. CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults.
Singh KK; Ellis RJ; Marquie-Beck J; Letendre S; Heaton RK; Grant I; Spector SA
J Neuroimmunol; 2004 Dec; 157(1-2):185-92. PubMed ID: 15579296
[TBL] [Abstract][Full Text] [Related]
39. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients.
Singh R; Kapoor R; Srivastava A; Mittal RD
Scand J Immunol; 2009 Jan; 69(1):51-6. PubMed ID: 19037908
[TBL] [Abstract][Full Text] [Related]
40. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
